Cover Focus

Emerging Options from the MS Treatment Pipeline

The MS pipeline is full of potential. Which therapies will be on the front line in tomorrow’s battle against MS?

By Zac Haughn, Senior Associate Editor

Relapsing and Progressive Multiple Sclerosis: Understanding the Differences

Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.

By Flavia Nelson, MD

Tysabri and MS: Putting the Odds in the Patient’s Favor

A recent analysis has created a better profile of who can receive Tysabri and when.

By Q&A with Robert J. Fox, MD

Feature Story

Five Steps to Qualifying for the Medicare EHR Meaningful Use Incentives

Physicians who do not meet the federal EHR meaningful use standards by October 2014 will face Medicare payment cuts of one percent in 2015; two percent in 2016.

By Zubin Emsley

The Most Unsettling Trends Facing Physicians: What to Expect and What to Do Today

The right approaches to financial planning can help protect and grow a physician’s assets, even as troubling trends persist.

By Brian Luster and Steven Abernathy

Departments

Expert Opinion

Spinal Injury from Electrocautery Shock

By Theodore Conliffe, MD; Zach Broyer, MD; Jonas Matzon, MD; Lisa Marino, DO; Pedro Beredjiklian, MD; Jeremy Simon, MD; and Michael Mehnert, MD Section Editor: Steven Mandel, MD

Dementia Insights

Cognitive Complications of Elective Surgery and Anesthesia

By Ronald Devere, MD, FAAN

Therapeutics Q&A

Botulinum Toxin for Urinary Incontinence